Details for New Drug Application (NDA): 211621
✉ Email this page to a colleague
The generic ingredient in ALOSETRON HYDROCHLORIDE is alosetron hydrochloride. There are three drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the alosetron hydrochloride profile page.
Summary for 211621
Tradename: | ALOSETRON HYDROCHLORIDE |
Applicant: | Eywa Pharma |
Ingredient: | alosetron hydrochloride |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 0.5MG BASE | ||||
Approval Date: | Sep 16, 2019 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 1MG BASE | ||||
Approval Date: | Sep 16, 2019 | TE: | RLD: | No |
Complete Access Available with Subscription